ArticleOncoimmunology2026

Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma.

Jesse R Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.